Özkan, S.; Gezer, D. The Impact of Dapagliflozin on FIB-4 Index over 2 Years in Patients With Type 2 Diabetes Mellitus. Eur Res J 2025, 11 (4), 676-682. https://doi.org/10.18621/eurj.1631079.